Matthew C. Hill, Chief Financial Officer at Apyx Medical Corp (APYX), bought 2,500 shares at $2.19 ($5K) on 2023-12-12, disclosed to the SEC on 2023-12-14.
Open-market purchase of $5k APYX by Chief Financial Officer. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Clearly above the average filing.
| Filing → |
| PDSB | BUY | 2021-12-14 | $27K | — | Filing → |
| SSKN | BUY | 2018-06-14 | $20K | — | Filing → |
| VLCR | BUY | 2008-05-28 | $4K | — | Filing → |